Concord Wealth Partners - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$69,000
-54.3%
1,585
-54.2%
0.02%
-51.3%
Q1 2022$151,000
-2.6%
3,459
-1.7%
0.04%
+2.6%
Q4 2021$155,000
+496.2%
3,520
+412.4%
0.04%
+245.5%
Q3 2021$26,000
-76.1%
687
-75.0%
0.01%
-64.5%
Q2 2021$109,000
+62.7%
2,744
+47.2%
0.03%
+34.8%
Q1 2021$67,000
+131.0%
1,864
+134.5%
0.02%
+4.5%
Q4 2020$29,0007950.02%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2022
NameSharesValueWeighting ↓
JTC Employer Solutions Trustee Ltd 6,324,319$241,621,00032.36%
Black Creek Investment Management Inc. 10,329,349$394,684,00011.46%
Healthcare Value Capital, LLC 100,000$3,821,0007.54%
KAHN BROTHERS GROUP INC 1,353,358$51,711,809,0007.28%
EQUITY INVESTMENT CORP 2,924,326$111,738,0004.28%
Eversept Partners, LP 1,503,700$57,456,3773.99%
NKCFO LLC 269,500$10,298,0003.45%
Robinson Value Management, Ltd. 96,990$3,706,0003.31%
Keystone Financial Planning, Inc. 237,691$9,082,0003.30%
CLIFFORD CAPITAL PARTNERS LLC 93,485$3,572,0003.27%
View complete list of GLAXOSMITHKLINE PLC shareholders